{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:45:32Z","timestamp":1763016332239},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,10,1]]},"DOI":"10.1038\/sj.bmt.1702624","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:48:20Z","timestamp":1031154500000},"page":"881-886","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study"],"prefix":"10.1038","volume":"26","author":[{"given":"S","family":"Tanikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Ohhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Hiruma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Sakamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,10,24]]},"reference":[{"key":"BF1702624_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE et al. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors Hepatology 1984 4: 116\u2013122","journal-title":"Hepatology"},{"key":"BF1702624_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/00007890-198907000-00016","volume":"48","author":"A Locasciulli","year":"1989","unstructured":"Locasciulli A, Bacigalupo A, Alberti A et al. Predictability before transplant of hepatic complications following allogeneic bone marrow transplantation Transplantation 1989 48: 68\u201372","journal-title":"Transplantation"},{"key":"BF1702624_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients Ann Intern Med 1993 118: 255\u2013267","journal-title":"Ann Intern Med"},{"key":"BF1702624_CR4","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KSK, Beschorner WF et al. Veno-occlusive disease of the liver following bone marrow transplantation Transplantation 1987 44: 778\u2013783","journal-title":"Transplantation"},{"key":"BF1702624_CR5","first-page":"197","volume":"10","author":"HM Schulman","year":"1992","unstructured":"Schulman HM, Hinterberger W . Hepatic veno-occlusive disease-liver toxicity syndrome after bone marrow transplantation Bone Marrow Transplant 1992 10: 197\u2013214","journal-title":"Bone Marrow Transplant"},{"key":"BF1702624_CR6","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1182\/blood.V81.12.3458.3458","volume":"81","author":"EM Faioni","year":"1993","unstructured":"Faioni EM, Krachmalnicoff A, Bearman SI et al. Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts development of venocclusive disease of the liver Blood 1993 81: 3458\u20133462","journal-title":"Blood"},{"key":"BF1702624_CR7","first-page":"497","volume":"8","author":"B Gordon","year":"1991","unstructured":"Gordon B, Haire W, Kessinger A et al. High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma Bone Marrow Transplant 1991 8: 497\u2013502","journal-title":"Bone Marrow Transplant"},{"key":"BF1702624_CR8","first-page":"471","volume":"11","author":"B Rio","year":"1993","unstructured":"Rio B, Bauduer F, Arrago JP et al. N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin Bone Marrow Transplant 1993 11: 471\u2013472","journal-title":"Bone Marrow Transplant"},{"key":"BF1702624_CR9","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1182\/blood.V83.10.3036.3036","volume":"83","author":"M Heikinheimo","year":"1994","unstructured":"Heikinheimo M, Halila R, Fasth A . Serum procollagen type III is an early and sensitive marker for veno-occlusive disease of the liver in children undergoing bone marrow transplantation Blood 1994 83: 3036\u20133040","journal-title":"Blood"},{"key":"BF1702624_CR10","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/sj.bmt.1700760","volume":"19","author":"YD Park","year":"1997","unstructured":"Park YD, Yasui M, Yoshimoto T et al. Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation Bone Marrow Transplant 1997 19: 915\u2013920","journal-title":"Bone Marrow Transplant"},{"key":"BF1702624_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/sj.bmt.1700689","volume":"19","author":"C Salat","year":"1997","unstructured":"Salat C, Holler E, Wolf C et al. Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation Bone Marrow Transplant 1997 19: 487\u2013490","journal-title":"Bone Marrow Transplant"},{"key":"BF1702624_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/scd.1.1996.5.79","volume":"5","author":"IA Tabbara","year":"1996","unstructured":"Tabbara IA, Ghazal CD, Ghazal HH . Early drop in protein C and antithrombin III is a predictor for the development of venoocclusive disease in patients undergoing hematopoietic stem cell transplantation J Hematother 1996 5: 79\u201384","journal-title":"J Hematother"},{"key":"BF1702624_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0049-3848(91)90176-W","volume":"63","author":"ML Scrobohaci","year":"1991","unstructured":"Scrobohaci ML, Drouet L, Monem-Mansi A et al. Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers Thromb Res 1991 63: 509\u2013519","journal-title":"Thromb Res"},{"key":"BF1702624_CR14","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V89.6.2184","volume":"89","author":"C Salat","year":"1997","unstructured":"Salat C, Holler E, Kolb H-J et al. Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation Blood 1997 89: 2184\u20132188","journal-title":"Blood"},{"key":"BF1702624_CR15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/sj.bmt.1701445","volume":"22","author":"JH Lee","year":"1998","unstructured":"Lee JH, Lee KH, Kim S et al. Relevance of protein C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study Bone Marrow Transplant 1998 22: 883\u2013888","journal-title":"Bone Marrow Transplant"},{"key":"BF1702624_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/0140-6736(93)91646-4","volume":"342","author":"M Eltumi","year":"1993","unstructured":"Eltumi M, Trivedi P, Hobbs JR et al. Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen Lancet 1993 342: 518\u2013521","journal-title":"Lancet"},{"key":"BF1702624_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s002770050194","volume":"73","author":"U Schuler","year":"1996","unstructured":"Schuler U, Subat S, Schmidt H et al. Evaluation of procollagen-III peptide as a marker for veno-occlusive disease after bone marrow transplantation Ann Hematol 1996 73: 25\u201328","journal-title":"Ann Hematol"},{"key":"BF1702624_CR18","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1136\/thx.39.10.726","volume":"39","author":"JME Kirk","year":"1984","unstructured":"Kirk JME, Bateman ED, Haslam PL et al. Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance Thorax 1984 39: 726\u2013732","journal-title":"Thorax"},{"key":"BF1702624_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2362.1979.tb00912.x","volume":"9","author":"H Rohde","year":"1979","unstructured":"Rohde H, Vargas L, Hahn E et al. Radioimmunoassay for type III procollagen peptide and its application to human liver disease Eur J Clin Invest 1979 9: 451\u2013459","journal-title":"Eur J Clin Invest"},{"key":"BF1702624_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/sj.bmt.1700895","volume":"20","author":"M Kami","year":"1997","unstructured":"Kami M, Mori S, Tanikawa S et al. Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution Bone Marrow Transplant 1997 20: 397\u2013402","journal-title":"Bone Marrow Transplant"},{"key":"BF1702624_CR21","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/sj.bmt.1701506","volume":"22","author":"S Hasegawa","year":"1998","unstructured":"Hasegawa S, Horibe K, Kawabe T et al. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors Bone Marrow Transplant 1998 22: 1191\u20131197","journal-title":"Bone Marrow Transplant"},{"key":"BF1702624_CR22","first-page":"253","volume":"12","author":"L Catani","year":"1993","unstructured":"Catani L, Gugliotta L, Mattioli Belmonte M et al. Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies Bone Marrow Transplant 1993 12: 253\u2013259","journal-title":"Bone Marrow Transplant"},{"key":"BF1702624_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0049-3848(92)90286-J","volume":"66","author":"C Seeber","year":"1992","unstructured":"Seeber C, Hiller E, Holler E et al. Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tissue necrosis factor alpha (TNF \u03b1) release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT) Thromb Res 1992 66: 373\u2013383","journal-title":"Thromb Res"},{"key":"BF1702624_CR24","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1182\/blood.V76.11.2284.2284","volume":"76","author":"VWM Vanhinsbergh","year":"1990","unstructured":"Vanhinsbergh VWM, Bauer K, Kooistra K et al. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1 and fibrin(ogen) degeneration products Blood 1990 76: 2284\u20132289","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702624","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702624.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702624.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T22:38:56Z","timestamp":1648075136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10,1]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2000,10,1]]}},"alternative-id":["BF1702624"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702624","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10,1]]},"assertion":[{"value":"2 March 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}